Approval · Notice of Compliance 20195 · 2017
ONSIOR: Notice of Compliance 20195
Issued December 22, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20195
- Date
- December 22, 2017
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional indications
Products in this notice
Medicinal ingredients
- ROBENACOXIB 5 MG per TAB
- ROBENACOXIB 10 MG per TAB
- ROBENACOXIB 20 MG per TAB
- ROBENACOXIB 40 MG per TAB